About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease

NCT04137926·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Yifeng Shen, M.D.
CONTACT
00862164387250 shenyifeng@yahoo.com

Lead

Shanghai Mental Health Center

Age

50–85

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

2011 NIA-AA criteria of MCI due to AD or AD

You may not be if

Non AD dementia

The record

StatusUnknown

PhaseNot applicable

Taking part360

StartedMar 2020

UpdatedSep 23, 2021

Conditions

Alzheimer's Disease

Where1

Department of Psychogeriatrics，Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China